Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DAN MONTANO OWES VT $1.7 MILLION
How can a bankrupt such as Dan possibly pay off this amount of award. VT must be happy as will the majority of VT shareholders.
Interesting. Please post the case details. I searched on PACER and there is no mention of any case brought by CVBT. Also, I'm interested in how you could you possibly know of any details on what CVBT people said??
Very strange!!
Zhittya Genesis Medicine announced they will starting a Parkinson's disease clinical trial in a few months. What is the status of Venturis (CVBT) study?
Seems to me Montano now only owes Venturis 1.7 million in which they will never receive. The tit for tat 1 million will wash and Venturis will keep plodding on. Nothing more needs to be said.
Zhittya Genesis Medicine DISMISSED from CVBT Lawsuit
In a lawsuit Cardiovascular Biotherapeutics filed against Zhittya Genesis Medicine, the Nevada State Court has dismissed Zhittya Genesis Medicine from the lawsuit. The lawsuit had that claimed that Zhittya Genesis Medicine was stealing trade secrets from CVBT which has since been thrown out of court.
The case was easily dismissed after CVBT'S OWN EXPERTS TESTIFIED THAT ZHITTYA GENESIS MEDICINE STOLE NOTHING FROM CVBT.
In a clear victory for Zhittya Genesis Medicine and Dan Montano, whose $1 million dollar judgement against Venturis Therapeutics will likely result in the downfall of CVBT, investors, including myself are wondering if CVBT will make it through 2021.
By the way, Zhittya Genesis Medicine in their Update also reports the development of intranasal delivery of their products. Is this something we should Venturis should be looking into?
Zhittya Genesis Medicine's Update reports they are developing a new cardiac catheter. Are we???
FEDERAL COURT CONFIRMS DAN MONTANO’S $1 MILLION DOLLAR CLAIM AGAINST CVBT
Mr. Dan Montano’s court victory confirmed by the federal court gives Mr. Montano an incredible vantage. With the universality of the federal court system this makes the claim good throughout the entire nation. In all 50 states and all territories of the United States CVBT owes Dan Montano $1 million dollars and attorney fees. This means that this decision is not only good in state of Nevada (where our former headquarters were), but also in the state of Texas!
I am genuinely concerned for the future of CVBT! With Dan Montano’s incredible vantage it is likely that CVBT won’t even make it through the debtors exam!
It was an award from a certain retired judge, Zimmerman. Nothing to do with Federal Courts.
My question is where the heck will Dan Montano get $1,700,000 to repay VT (the $2,500,000 award to Wallen, now VT, less the $800,000 awarded in back wages to DM)?
Also, as DM is still in bankruptcy will his creditors take action to get hold of the $800,000?
I've heard that the Shareholder Meeting has been slated for June 2021. As I understand it it'll be announced shortly together with some other very interesting and positive news. From my keyboard to GOD'S ears.
I believe this is a big deal for VT, particularly as it has the IP protection around it. In the most recent presentation from VT it has a statement from Chairman of the Board of Directors, Novo Nordisk as follows:-
Patents at the Core: the Biotech Business
World Intellectual Property Organisation - WIPO
“Anyone, I would imagine, who has tried
to create a biotech company knows just how important patents are. You learn this when you’re studying, and again at your first job, and if you haven’t done so before, you realize it the first time you
meet potential investors.”
Mads Øvlisen, Chairman of the Board of
Directors, Novo Nordisk
I would like to share the presentation with y'all but as I signed an NDA before they would send it to me, I need to check out whether I'd get into trouble for sending a link to it here.
I hope everyone has a great weekend.
Johnny & all other "VT supporters" you appear to have missed my post yesterday. I am happy to reiterate.
"I have excellent news for you Johnny & all other VT supporters. The judgement (which had nothing to do with Federal Court, it was arbitration), amounts to slightly over $800,000 of back wages. The problem for Dan is that the $2.5 million awarded to Calvin Wallen a few years ago has been assigned to VT so Dan now owes VT $1.7 million. I am sure that's a relief to all concerned. Where do you think that Dan Montano, who is still bankrupt, will be able to come up with that sort of cash?
I guess good old Dan is in a bit of a pickle.
A sad day all round for Zhittya & Dan Montano personally.
By the way, this information came from someone very closely involved in these matters."
DEBTORS EXAM FOR CARDIOVASCULAR BIOTHERAPEUTICS (CVBT)/VENTURIS THERAPEUTICS
Rumor has it that as a result of Dan Montano's court victory, which has given him a judgment of a $1 million dollar claim against Venturis Therapeutics, confirmed by the Federal Court, that Dan Montano will be seeking a debtors exam for CVBT in the month of May. I am worried that this debtors exam will reveal the true financial position of CVBT/Venturis Therapeutics and make the CVBT directors liable.
How will this debtor's exam affect the future of CVBT? Will there be a future for CVBT following this major legal victory for Daniel C. Montano? Where will CVBT get the $1 million dollars to pay Mr. Dan Montano?
THE UNITED STATES FEDERAL COURT HAS CONFIRMED DAN MONTANO'S ONE MILLION DOLLAR CLAIM AGAINST CVBT/VENTURIS THERAPEUTICS
Furthermore, with Zhittya Genesis Medicine and Mrs. Montano being ENTIRELY DISMISSED from the lawsuits that Venturis brought fourth there is a clear path for Mr. Daniel Montano to forcibly collect on his 1 million dollar claim. Venturis is at the hands of Dan Montano! Why were we not made aware of this? Why is our administration so quick to announce when lawsuits are filed but not when we are miserably defeated and punished for our defeat?
I worry that Mr. Montano will wipe Venturis off the face of the map with his new ability to forcibly collect on his one million dollar award which has been confirmed by the United States Federal Court.
I presume that the news that people may need a COVID booster shot each year, similar to the flu shot, that Venturis' COVID program will be much more valuable now, particularly with the new IP surrounding it.
It wasn't a lawsuit it was arbitration. As far as I'm aware the language in the arbitrator's report was that VT could pay the award when it suited its cash-flow. Regarding the amount Dan Montano owes Venturis, maybe we should have a whip round to see if we can help Dan with amount he owes. I will put up $10 - anyone else?
I am new to this. It sounds like good news but why does Dan Montano owe VT $1.7m? Is that why Dan Montano is bankrupt?
I forgot the other bit of good news. The case between Gloria's Ranch & Tauren (Calvin Wallen) has been settled by the parties out of court. In fact I was just on the PACER website & it confirms the case is closed as per:
Filed & Entered: 04/12/2021
Docket Text Close adversary case
That must be a relief to all posters on the board.
I have excellent news for you Johnny & all other VT supporters. The judgement (which had nothing to do with Federal Court, it was arbitration), amounts to slightly over $800,000 of back wages. The problem for Dan is that the $2.5 million awarded to Calvin Wallen a few years ago has been assigned to VT so Dan now owes VT $1.7 million. I am sure that's a relief to all concerned. Where do you think that Dan Montano, who is still bankrupt, will be able to come up with that sort of cash?
I guess good old Dan is in a bit of a pickle.
A sad day all round for Zhittya & Dan Montano personally.
By the way, this information came from someone very closely involved in these matters.
I guess Zhittya Genesis Medicine and Daniel Montano will now be taking off and devaluing the position of us CVBT Shareholders. Venturis (CVBT) made it sound like they won the lawsuit!
Zhittya Genesis Medicine Inc., (formerly known as Zhittya Regenerative Medicine), competitor to Cardiovascular Biotherapeutics Inc., has announced its CEO, Daniel C. Montano, has been awarded an over $1 million legal judgement, confirmed by the US Federal Court, against CVBT and its new name, Venturis Therapeutics.
Mr. Dan Montano is now pursuing the involuntary collections of his judgements against CVBT.
Zhittya Genesis Medicine also announced that ALL legal allegations made against Zhittya Genesis Medicine have been DISMISSED by the judge.
After seven years of lawsuits by CVBT against Zhittya it is clear that CVBT has come out as the ultimate loser after this judgement against them for $1 million. In all this time, CVBT has FAILED TO CONDUCT CLINICAL TRIALS, MANUFACTURE THE DRUG, OR PAID ANY PART OF ITS $30 MILLION IN DELINQUENT BILLS.
This is the final nail in the coffin.
Sayanora and goodbye, Venturis/CVBT.
But maybe we'll hear all the great news taking place at the 2021 shareholders meeting in May 2021, right?
Daniel C. Montano wins a ONE MILLION DOLLAR JUDGEMENT against Venturis Therapeutics(fka CVBT)
In an unfortunate turn of events for our administration, the arbitration case initiated by Venturis Therapeutics against Mr. Daniel Montano has resulted in Dan Montano winning a one million dollar judgement against Venturis Therapeutics as well as attorneys' fees and costs; confirmed by the US Federal Court.
Mr. Montano is now pursuing the involuntary collections of his judgment against Venturis, which will include a judgment debtor discovery against Venturis Therapeutics so that Mr. Montano can seize the assets of the company and satisfy the terms of his judgement.
Even worse for Venturis: Other litigation initiated by Venturis against Mrs. Montano and Zhittya Genesis Medicine (commonly referred to as Zhittya) has been DISMISSED by the Nevada State courts.
THIS IS A CLEAR VICTORY FOR DAN MONTANO AND ZHITTYA. After this judgement I will be surprised if Venturis Therapeutics makes it through 2021.
Daniel C. Montano has won a judgement in excess of $1,000,000, which has been confirmed by the US Federal Court, against Venturis Therapeutics Inc., formerly known as CardioVascular BioTherapeutics, Inc.
The $1,000,000+ judgment was awarded in an arbitration case actually initiated by Venturis against Mr. Montano wherein all but a fraction of Venturis' case was summarily dismissed and Mr. Montano was awarded over $1,000,000 and attorneys' fees and costs.
Daniel Montano is now pursuing the involuntary collections of his judgment against Venturis including judgment debtor discovery against Venturis in order to seize assets from this company to satisfy the judgment.
In other litigation initiated by Venturis against Mrs. Montano, John Laub, and Zhittya, the Nevada State court similarly dismissed all claims brought by Venturis.
April 15, 2021
The non-existent 2021 shareholders meeting, Venturis Therapeutics/CVBT
Since Venturis Therapeutics (formerly Cardiovascular Biotherapeutics/CVBT) gave its shareholders the middle finger in 2020 by not holding a shareholders meeting as required by the company's bylaws, don't hold your breath there will be a 2021 one. In fact, I'd be shocked if it happens. Given that the shareholders meeting is supposed to be 1.5 months away, and given that we have heard nothing about any such meeting, it is likely we will get a middle finger from the leadership of this company for the second straight year running.
Do we have a functioning Board of Directors of this company? If so, why are they allowing this to happen?
Venturis has showed us with its actions that it does not give a damn about the investors. We have been told many lies and I still remember Calvin Wallen III telling us that under his leadership we could look forward to regular updates and annual shareholders meetings. What a lie that was.
Prove me wrong, Venturis. I look forward to hearing about the (current non-existent) 2021 shareholders meeting in May as required by the company's bylaws...and ESPECIALLY by its promises to us.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161470601
More false Venturis Therapeutics/CVBT promises
Has anyone else noticed that for the last 4 years running, Venturis Therapeutics (previously Cardiovascular Biotherapeutics) has continually "updated" its postings on clinicaltrials.gov, indicating that Venturis's clinical trials are going to re-commence 6-12 months out, yet as time gets closer to those indicated dates, the company instead changes them again further out? The fact is, this has been continuously happening over and over and over again since 2016. The dates keep changing, but the results do not. Not a single clinical trial has been run since 2008. That is a fact.
I made some inquiries, and I learned that postings on clinicaltrials.gov are made by the companies themselves, not the government. It's an honors sytem. Well, that doesn't work when dishonest players who post things that are not true are seeking to manipulate the system for their own purposes, in order to create an impression to the uninformed which doesn't conform to reality. My best guess in this case is Venturis has been trying to create the impression with possible investors that "things are happening" when they're not. Venturis is dead dead dead, and in my opinion we the shareholders have been screwed by the lies of this current leadership team and Mr. Wallen in particular.
Anyway...this tired game no longer fools anyone. I'm awaiting the final bankruptcy filing which I believe is imminent.
For more information about this failed company and the alleged crook who is its CEO and controlling shareholder, read here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
Correct me if I'm wrong - didn't Calvin Wallen IN WRITING promise shareholders during the proxy takeover battles that he would hold shareholders meetings every year (at a time when Dan Montano was not, as a way of contrasting how things would be different under new leadership of CVBT)?
Yes, he did. So don't quote me the law, because that's BS and flies in the face of what Mr. Wallen publicly promised all of us.
CALVIN WALLEN LIED. It's that simple. And as the U.S. government has charged in their case against Calvin Wallen III, lying (and fraud, and theft) seems to be a "thing" with him.
For more information about this failed company and the alleged crook who is its CEO and controlling shareholder, read here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
I'm saying by Law they are not required to have meeting until they get relisted
Help me understand your argument - you're saying since Venturis/CVBT was not a public company in 2020 there was no shareholders meeting. Yet there were annual shareholders meetings in 2019, 2018, 2017 - does this mean you're saying Venturis/CVBT was public during those years?
Not a public company therefore no meeting requirements.
Dead & Deader: The aftermath of Venturis/CVBT taken over by an alleged crook
All that awaits Venturis Therapeutics shareholders is the inevitable bankruptcy filing after having lost a 7-figure judgment at the hands of its former CEO, Dan Montano. Venturis is deader than Herman Cain. This was the inevitable result when an alleged crook, Calvin Wallen, took over Cardiovascular Biotherapeutics (or CVBT, as this company was called before the name was changed to Venturis Therapeutics) based on false promises (also known as lies) made to shareholders.
BTW, no shareholders meeting was held in 2020, in VIOLATION of the company's bylaws and promises made to shareholders by Calvin Wallen III. Further, a series of lies were anonymously disseminated promising that the shareholders meeting would be held in the fall of 2020 when it didn't happen in May 2020 as was required. Well, we know how that played out.
A shareholder recently reported calling the company. No one answered the phone, so the shareholder left a message. Was the message returned? Of course not! Dead, dead, dead, deader, deadest...you pick.
As for the alleged crook Mr. Wallen (and it will be nice to be able to soon drop the word "alleged"), we will be learning soon when his upcoming trial brought by the U.S. government will take place, for allegedly stealing $14 million from his previous company, Tauren Exploration. Mr. Wallen has pursued a scorched earth approach to delaying his trial, with an assist from coronavirus, but the law is coming for him. While some form of "settlement" was supposedly reached late in 2020, the date came and went in December 2020 when it was supposed to be publicly presented to the bankruptcy court. What happened? We will find out soon. A hearing is scheduled for next week, and the smart money has it that the attorneys for both sides will tell the judge that the "settlement" failed and the case should now proceed to trial. Let's see what happens. Once the trial happens and assuming Mr. Wallen loses the case (a near-certainty), it will be interesting to see what the IRS does, since even stolen money is taxable for the thief (and at that point we can drop the word "alleged"). I wonder if Mr. Wallen paid taxes on that $14 million? We will eventually find out.
For more information about this failed company and the alleged crook who is its CEO and controlling shareholder, read here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
I'm sorry to hear about your father's passing.
I don't think anyone outside of CVBT/Venturis leadership would suggest the shares have any value at all. They're all but certainly worthless, and this company is all but certainly dead.
That said, if you want to transfer the title of the shares, you should contact the company directly and they should be willing to assist you.
That is, assuming they return your call. I would not take that bet.
Advise wanted,
My late father passed away with a cvbt holding of which i now hold the share certificates how do i go about having them transferred into my name as the executor of the Will ?
(Assuming something comes good of cvbt)
Too busy fighting lawsuits
NEWS FLASH: In 2020 there was no annual shareholders meeting, in violation of the company's bylaws and promises made by leadership.
Where's the accountability?
More coming...
The number of failed predictions is hilarious. The only thing more laughable than the number of failed predictions is the current state of the world class social media campaign that was held up high by someone. Followed closely by the HUGE monopoly money investment by RMO in Shitya. It's amazing what that HUGE cash infusion did for them. Hahahahhahaha
With regards to Venturis being re-listed, there is a greater chance that the coronavirus pandemic will be over and not a single case will be found in the U.S. on January 1, 2021, than there is that Venturis will be re-listed in 2021.
No being relisted, hopefully 2021 will be the year
Montano or his minion already has
Are you referring to the bankruptcy filing?
When are we going to hear some good news?
I wish Dan Montano, who has been through more bankruptcies than anyone I know, would weigh in on this one. He is truly the expert of "scorched earth" tactics and navigating bankruptcy and government sanctions/scrutiny.
Key question: How seriously will the IRS take a referral for possible tax evasion coming from a U.S. government bankruptcy trustee?
Will it be relegated to "the pile" that they get to when they get to, or is it going to receive prioritized and/or heightened scrutiny?
Venturis supporter, I'd love to hear your thoughts on this.
All that the legal filing says is that the parties have reached a settlement. It says nothing as to what that settlement is. However, the settlement is going to be presented to the court, so we will get to see the terms very soon. And you can be sure I will share the terms with the public.
Brace yourself Venturis supporters, it's not going to be pretty. I can't wait to see the public acknowledgements Mr. Wallen will be admitting to.
If Mr. Wallen publicly acknowledges responsibility in any way shape or form, it's over for Venturis. Not one investor is going to ever put another dime into anything that Wallen does, whether Venturis or anything else. So let's see what's coming.
And by the way, if Mr. Wallen acknowledges having taken any of the money from Tauren in any way, shape, or form, even if he returns any part of it, this settlement is hardly the end of his problems. The IRS is going to want to take a look into whether there has been any tax evasion as well. For the record, tax evasion is a criminal felony. F-E-L-0-N-Y. And with 100% certainty, the bankruptcy trustee is going to make sure the IRS gets notification of this settlement as well. That sort of going-the-extra-mile is what happens when a-holes antagonize government officials, if the rumors are true. Scorched earth tactics come at a cost.
So unless the settlement is a complete vindication of Calvin Wallen III--and there's exactly a 0% chance of that--this is far from the end of Mr. Wallen's problems in this matter.
Look it up yourself. You have pretended to be the expert on Tauren and Calvin's legal trifles. But most likely he agreed to buy his Oil and Gas buddies a cup of coffee to dismiss the cases. I realize that is tough for you to hear.
Montano ruined this company and it still has not recovered. Another year of being delisted, bah humbug.
So Calvin Wallen pled guilty?
And how much of the stolen $14 million is he returning to Tauren?
It's a shame you wasted all that effort typing that. Tauren case was just settled. Another failed prediction. HAHAHAHA
The lies of Venturis Therapeutics leadership
Here we are at the end of November 2020, and Venturis not only hasn't held the annual shareholders meeting in 2020 in violation of the company's bylaws (which was supposed to take place in May 2020), but worse, Venturis has not publicly said a thing about this gross abdication of its responsibilities to its shareholders. While someone (in my opinion a member of the leadership team) anonymously indicated the meeting had been re-scheduled to sometime in the fall of 2020, obviously that never happened. There's 30 days left for this meeting to ever take place in 2020. Don't hold your breath.
In my opinion, Venturis has collapsed under the weight of years of its own lies. Lies that were used to gather support for the hostile takeover of Cardiovascular Biotherapeutics (CVBT), lies that were disseminated by leadership throughout its failed tenure since 2014 which I have documented, and lies anonymously shared that have suggested huge investment, investment bankers raising funding, etc., none of which has remotely happened. It's all been one giant pile of stinking lies.
But why should anyone have thought it would end differently? Anyone who did even a modicum of due diligence on Calvin Wallen III would have seen all sorts of red flags. And was anyone surprised when the U.S. government filed a lawsuit against Mr. Wallen to recover the $14 million he allegedly stole from his previous company, Tauren Exploration, before Tauren filed for bankruptcy as a consequence of Mr. Wallen's stellar leadership? To Mr. Wallen's credit, he has been able to delay, delay, delay judgment day in court by pursuing a scorched earth approach to his upcoming trial, and he got a huge assist from coronavirus adding to that delay. But the law is coming, and I would guess that in 2021 Mr. Wallen will finally have his day in court. It's clear to me it won't end well for him.
I've read the government's charges against Mr. Wallen and the preliminary evidence, where the government provide dates, amounts, and destination bank accounts of the monies Mr. Wallen allegedly stole from Tauren. This information was put together by a forensic accountant hired by Tauren's bankruptcy trustee, and he revealed the alleged fraud for all to see. I can't imagine there's any credible defense Mr. Wallen can mount. But one thing's for sure: If he was so sure he is innocent, why has Mr. Wallen done everything possible to put off the start of his own trial? We all know the answer to that question.
All that remains is the upcoming Venturis Therapeutics bankruptcy filing.
For more information about this failed company and the alleged crook who is its CEO and controlling shareholder, read here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
Dead&Deader: When an alleged crook took over CVBT (now called Venturis Therapeutics)
All that awaits Venturis Therapeutics shareholders is the inevitable bankruptcy filing after having lost a 7-figure judgment at the hands of its former CEO, Dan Montano. Venturis is deader than King Tut. This was the inevitable consequence when an alleged crook, Calvin Wallen, took over CVBT based on a slate of false promises (also known as lies) made to shareholders.
By the way, we're now almost SIX MONTHS PAST DUE from when there was supposed to be a shareholders meeting in 2020. Perhaps it will still happen, in December, at the North Pole, with Santa Claus joining the Board of Directors. Or more likely, there will never be another shareholders meeting ever again.
As for Mr. Wallen, we will be learning soon when his upcoming trial brought by the U.S. government will take place, for allegedly stealing $14 million from his previous company, Tauren Exploration. Mr. Wallen has pursued a scorched earth approach to delaying his trial, with an assist from coronavirus, but the law is coming for him. The day of reckoning will likely occur in 2021. And assuming Mr. Wallen loses the case, it will be interesting to see what the IRS does, since even stolen money is taxable for the thief (and at that point we can drop the word "alleged"). I wonder if Mr. Wallen paid taxes on that $14 million? We will eventually find out.
For more information about this failed company and the alleged crook who is its CEO and controlling shareholder, read here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156705047
Followers
|
39
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3648
|
Created
|
04/08/05
|
Type
|
Free
|
Moderators |
VENTURIS THERAPEUTICS (formerly Cardiovascular
Biotherapeutics or CVBT) is a dead, zombie company
that hasn't run a single clinical trial in nearly 15
years. Not even one patient (!) has been treated
since 2007. Venturis Therapeutics is insolvent,
illiquid, and is controlled and run by an individual
who was accused by the U.S government of
embezzling $14 million from his previous company.
Venturis' lawyer, Barry Cannaday of Dentons (one
of the largest law firms in the U.S.), withdrew from
representing Venturis in April 2021 because Dentons
is owed over $200,000 by Venturis, and Mr. Cannaday
attested that "there are currently no assets or
revenue streams" to pay Dentons. Yet anonymous
advocates for Venturis (who I personally believe are
the company's desperate leadership) lie about public
facts that are easily verifiable. One of the most
absurd false claims is that there are (allegedly) two
ongoing pivotal clinical trials (see that particular
false claim below). These "clinical trials" exist only
in cyberspace but not in the real world the rest of us
(including Dentons) live in. That said, enjoy the
entertainment that lies below. Hopefully it gives you
some good laughs - that's about all that's left from
this dead, zombie company. Enjoy!
VENTURIS THERAPEUTICS (VT) OVERVIEW
VT was almost bankrupted by the original
CEO, Daniel C. Montano, and was rescued by
Calvin Wallen, Grant Gordon and then CFO,
Mickael Flaa.
VT had almost $40,000,000 in debt & was
effectively insolvent. The board of directors
who replaced the Dan Montano cronies
rehabilitated VT so that today the company has
almost zero debt and an comprehensive patent
portfolio. Under the disasterous management
of Dan Montano, the company had zero
patents.
Our Approach in Science and Technology:
Venturis Therapeutics, Inc. is a clinical stage
biopharmaceutical company advancing novel
therapeutics to address diseases such as
diabetic wounds, severe ischemic heart disease
and
peripheral artery disease. Our pre-clinical
therapeutic programs include erectile
dysfunction,
infarct stroke, degenerative disk disease and
Parkinson’s Disease.
Venturis Therapeutics, Inc. is focused on
targeted delivery of next generation
molecules which will improve the quality of life
for those suffering from vascular dysfunction.
We employ human proteins from the Fibroblast
Growth Factor family. Our lead candidate
stimulates the growth of new blood vessels when
administered to ischemic organs and
tissues. These anatomical targets are shown in
our pipeline section of the website.
www.vt.care
VENTURIS THERAPEUTICS (VT) OVERVIEW
VT was almost bankrupted by the original
CEO, Daniel C. Montano, and was rescued by
Calvin Wallen, Grant Gordon and then CFO,
Mickael Flaa.
VT had almost $40,000,000 in debt & was
effectively insolvent. The board of directors
who replaced the Dan Montano cronies
rehabilitated VT so that today the company has
almost zero debt and an comprehensive patent
portfolio. Under the disasterous management
of Dan Montano, the company had zero
patents.
Our Approach in Science and Technology:
Venturis Therapeutics, Inc. is a clinical stage
biopharmaceutical company advancing novel
therapeutics to address diseases such as
diabetic wounds, severe ischemic heart disease
and
peripheral artery disease. Our pre-clinical
therapeutic programs include erectile
dysfunction,
infarct stroke, degenerative disk disease and
Parkinson’s Disease.
Venturis Therapeutics, Inc. is focused on
targeted delivery of next generation
molecules which will improve the quality of life
for those suffering from vascular dysfunction.
We employ human proteins from the Fibroblast
Growth Factor family. Our lead candidate
stimulates the growth of new blood vessels when
administered to ischemic organs and
tissues. These anatomical targets are shown in
our pipeline section of the website.
www.vt.care
VENTURIS THERAPEUTICS OVERVIEW
Our Approach in Science and Technology:
Venturis Therapeutics, Inc. is a clinical stage biopharmaceutical company advancing novel
therapeutics to address diseases such as diabetic wounds, severe ischemic heart disease and
peripheral artery disease. Our pre-clinical therapeutic programs include erectile dysfunction,
infarct stroke, degenerative disk disease and Parkinson’s Disease.
Venturis Therapeutics, Inc. is focused on targeted delivery of next generation
molecules which will improve the quality of life for those suffering from vascular dysfunction.
We employ human proteins from the Fibroblast Growth Factor family. Our lead candidate
stimulates the growth of new blood vessels when administered to ischemic organs and
tissues. These anatomical targets are shown in our pipeline section.
vt.care
Venturis Therapeutics (VT) is
a biotechnology company based
in Dallas, Texas. VT has pivotal trials
ongoing in Ischemic Heart Disease &
Diabetic Foot Ulcers.
VT has a comprehensive patent
portfolio protecting its therapeutic
programs.
Venturis Therapeutics (VT) is
a biotechnology company based
in Dallas, Texas. VT has pivotal trials
ongoing in Ischemic Heart Disease &
Diabetic Foot Ulcers.
VT has a comprehensive patent
portfolio protecting its therapeutic
programs.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |